{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:18:16Z","timestamp":1790705896425,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":2442,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"crossref","award":["P30AI036211"],"award-info":[{"award-number":["P30AI036211"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NCI","award":["P30CA125123"],"award-info":[{"award-number":["P30CA125123"]}]},{"DOI":"10.13039\/100000097","name":"NCRR","doi-asserted-by":"crossref","award":["S10RR024574"],"award-info":[{"award-number":["S10RR024574"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","exphem.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.exphem.2015.05.013","type":"journal-article","created":{"date-parts":[[2015,6,13]],"date-time":"2015-06-13T12:20:06Z","timestamp":1434198006000},"page":"912-918.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Comparative long-term effects of interferon \u03b1 and hydroxyurea on human hematopoietic progenitor cells"],"prefix":"10.1016","volume":"43","author":[{"given":"Katherine Y.","family":"King","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie A.","family":"Matatall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Chieh","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A.","family":"Goodell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina I.","family":"Swierczek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef T.","family":"Prchal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2015.05.013_bib1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1365-2125.2007.03055.x","article-title":"Clinical uses of interferons","volume":"65","author":"Friedman","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.exphem.2015.05.013_bib2","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1182\/blood-2006-03-009860","article-title":"High molecular response rate of polycythemia vera patients treated with pegylated interferon alpha-2a","volume":"108","author":"Kiladjian","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.013_bib3","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1586\/ehm.11.63","article-title":"A new era for IFN-alpha in the treatment of Philadelphia-negative chronic myeloproliferative neoplasms","volume":"4","author":"Hasselbalch","year":"2011","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.exphem.2015.05.013_bib4","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1056\/NEJMoa1004095","article-title":"Imatinib plus peginterferon alfa-2a in chronic myeloid leukemia","volume":"363","author":"Preudhomme","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2015.05.013_bib5","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.exphem.2010.03.005","article-title":"Interferon-alpha targets JAK2V617F-positive hematopoietic progenitor cells and acts through the p38 MAPK pathway","volume":"38","author":"Lu","year":"2010","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2015.05.013_bib6","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.4049\/jimmunol.135.4.2507","article-title":"Studies of interferon as a regulator of hematopoietic cell proliferation","volume":"135","author":"Raefsky","year":"1985","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2015.05.013_bib7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1023\/A:1023668705040","article-title":"Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis","volume":"8","author":"Chawla-Sarkar","year":"2003","journal-title":"Apoptosis"},{"key":"10.1016\/j.exphem.2015.05.013_bib8","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nature07815","article-title":"IFNalpha activates dormant haematopoietic stem cells in\u00a0vivo","volume":"458","author":"Essers","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2015.05.013_bib9","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nature09135","article-title":"Quiescent haematopoietic stem cells are activated by IFN-\u03b3 in response to chronic infection","volume":"465","author":"Baldridge","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2015.05.013_bib10","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1182\/blood-2011-01-328682","article-title":"Irgm1 protects hematopoietic stem cells by negative regulation of IFN signaling","volume":"118","author":"King","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.013_bib11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1084\/jem.20131043","article-title":"Re-entry into quiescence protects hematopoietic stem cells from the killing effect of chronic exposure to type I interferons","volume":"211","author":"Pietras","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2015.05.013_bib12","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/01.moh.0000154029.05396.d2","article-title":"Polycythemia vera and other primary polycythemias","volume":"12","author":"Prchal","year":"2005","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.exphem.2015.05.013_bib13","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2015.05.013_bib14","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1182\/blood.V96.13.4185","article-title":"Human hematopoietic stem cells stimulated to proliferate in\u00a0vitro lose engraftment potential during their S\/G(2)\/M transit and do not reenter G(0)","volume":"96","author":"Glimm","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.013_bib15","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.exphem.2006.12.007","article-title":"In\u00a0vitro expansion of erythroid progenitors from polycythemia vera patients leads to decrease in JAK2 V617F allele","volume":"35","author":"Gaikwad","year":"2007","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2015.05.013_bib16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.exphem.2006.11.012","article-title":"Polycythemia vera is not initiated by JAK2V617F mutation","volume":"35","author":"Nussenzveig","year":"2007","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2015.05.013_bib17","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/j.1460-2075.1988.tb02872.x","article-title":"Interferon-induced binding of nuclear factors to promoter elements of the 2-5A synthetase gene","volume":"7","author":"Rutherford","year":"1988","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2015.05.013_bib18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0014-5793(86)80224-1","article-title":"Full-length sequence and expression of the 42 kDa 2-5A synthetase induced by human interferon","volume":"196","author":"Wathelet","year":"1986","journal-title":"FEBS Lett"},{"key":"10.1016\/j.exphem.2015.05.013_bib19","doi-asserted-by":"crossref","first-page":"5186","DOI":"10.1182\/blood-2006-08-044503","article-title":"Studies of c-Mpl function distinguish the replication of hematopoietic stem cells from the expansion of differentiating clones","volume":"109","author":"Abkowitz","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.013_bib20","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1182\/blood-2011-02-334680","article-title":"PR-domain-containing Mds1-Evi1 is critical for long-term hematopoietic stem cell function","volume":"118","author":"Zhang","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.013_bib21","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1073\/pnas.95.3.1195","article-title":"Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin","volume":"95","author":"Kimura","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2015.05.013_bib22","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.1371\/journal.pbio.0050201","article-title":"Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation","volume":"5","author":"Chambers","year":"2007","journal-title":"PLoS Biol"},{"key":"10.1016\/j.exphem.2015.05.013_bib23","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1002\/stem.1799","article-title":"Type II Interferon promotes differentiation of myeloid-biased hematopoietic stem cells","volume":"32","author":"Matatall","year":"2014","journal-title":"Stem Cells"},{"key":"10.1016\/j.exphem.2015.05.013_bib24","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.yexcr.2014.08.017","article-title":"Pro-inflammatory cytokines: emerging players regulating HSC function in normal and diseased hematopoiesis","volume":"329","author":"Mirantes","year":"2014","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.exphem.2015.05.013_bib25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.stem.2014.04.016","article-title":"Quiescent hematopoietic stem cells accumulate DNA damage during aging that is repaired upon entry into cell cycle","volume":"15","author":"Beerman","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2015.05.013_bib26","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1084\/jem.20111490","article-title":"Clonal analysis reveals multiple functional defects of aged murine hematopoietic stem cells","volume":"208","author":"Dykstra","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2015.05.013_bib27","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1182\/blood-2012-05-432989","article-title":"Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon-\u03b1 in a murine model of polycythemia vera","volume":"121","author":"Mullally","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.013_bib28","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1182\/blood-2013-04-498956","article-title":"JAK2V617F expression in mice amplifies early hematopoietic cells and gives them a competitive advantage that is hampered by IFN\u03b1","volume":"122","author":"Hasan","year":"2013","journal-title":"Blood"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X15001952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X15001952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T12:01:57Z","timestamp":1691755317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X15001952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0301472X15001952"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2015.05.013","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative long-term effects of interferon \u03b1 and hydroxyurea on human hematopoietic progenitor cells","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2015.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}